Q-omics provides the consensus-scored IGLJ4 profile across patient tissues and cancer cell-line models. IGLJ4 expression is associated with patient survival in 5 of 34 cancer types, with the highest sampling consensus in UCEC. Additionally, IGLJ4 RNA expression shows 5,311 significant gene co-expression associations, with the highest sampling consensus in SKCM. Together, these results highlight UCEC, and SKCM as cancer lineages where IGLJ4 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.